Spend three focused days alongside leading experts exploring the advances reshaping Alzheimer’s care, from earlier diagnosis and biomarker use to emerging therapies and long-term disease management.
Explore evolving diagnostic frameworks, cognitive assessment, differential diagnosis, and earlier identification of disease.
Examine how CSF, PET, and emerging blood-based biomarkers are influencing clinical evaluation and decision-making.
Navigate current evidence, disease-modifying therapies, patient selection, monitoring, and real-world treatment considerations.
Strengthen your approach to the broader spectrum of dementias and the complex presentations encountered in clinical practice.
Consider neuropsychiatric symptoms, caregiver support, risk reduction, progression, and longitudinal care planning.
Learn across specialties and examine how coordinated care can support patients and caregivers throughout the disease continuum.
See How Three Days of Education Come Together in Orlando.
View the 2026 AgendaHear directly from clinicians who have experienced ADCD for themselves.
Explore the Featured Speakers
View FacultyDesigned for healthcare professionals across specialties to explore evolving approaches to neurologic and cognitive care.
The Alzheimer’s Disease & Cognitive Disorders Symposium, or ADCD, is an in-person continuing education meeting for clinicians involved in Alzheimer’s disease, dementia, and cognitive care. The program focuses on practical education across diagnosis, biomarkers, treatment planning, neuropsychiatric symptom management, caregiver support, and multidisciplinary care.
ADCD Symposium 2026 will take place December 4–6, 2026, at the Hyatt Regency Grand Cypress in Orlando, Florida.
The program covers timely clinical topics across Alzheimer’s disease, dementia, and cognitive disorders, including diagnostic criteria, cognitive assessment, biomarkers, disease-modifying therapies, neuropsychiatric symptoms, risk reduction, caregiver support, shared decision-making, long-term care planning, and complex case management.
No. ADCD is intentionally multidisciplinary. Neurologists are an important part of the program, but the education also brings together psychiatry, geriatrics, primary care, advanced practice, nursing, and other professionals involved in Alzheimer’s disease and dementia care.
Alzheimer’s disease and dementia care continue to change as diagnostic pathways evolve, biomarker use expands, new treatment considerations emerge, and care becomes increasingly multidisciplinary. ADCD is built to help clinicians examine those changes and translate them into real-world patient care.